share_log

Novavax | 8-K: Settlement Agreement

Novavax | 8-K: Settlement Agreement

诺瓦瓦克斯医药 | 8-K:和解协议2024年6月13日,该公司与Jefferies LLC(以下简称Jefferies)签署了一份和解协议和解放(以下简称“和解协议”),根据该协议,Jefferies同意调整公司欠款的某些未决承销费,在解决Jefferies所欠费用的情况下,公司同意(i)支付Jefferies 150万美元,条件是公司融资交易完成后获得至少1500万美元的毛收益,以及(ii)向Jefferies发行100万个认股权证,每个认股权证将使持有人有权行使1股普通股,行权价格为每股11.50美
美股SEC公告 ·  11/05 17:06

Moomoo AI 已提取核心信息

On November 1, 2024, Novavax, Inc. entered into a Termination and Settlement Agreement with the UK Health Security Agency, effectively resolving disputes related to the Amended and Restated SARS-COV-2 Vaccine Supply Agreement dated July 1, 2022. The settlement includes Novavax's commitment to refund $123.8 million to the Authority in quarterly installments over three years, with the option to avoid interest by accelerating payments. The first installment is due on November 30, 2024. This agreement concludes the obligations and claims of both parties under the previous supply agreement.
On November 1, 2024, Novavax, Inc. entered into a Termination and Settlement Agreement with the UK Health Security Agency, effectively resolving disputes related to the Amended and Restated SARS-COV-2 Vaccine Supply Agreement dated July 1, 2022. The settlement includes Novavax's commitment to refund $123.8 million to the Authority in quarterly installments over three years, with the option to avoid interest by accelerating payments. The first installment is due on November 30, 2024. This agreement concludes the obligations and claims of both parties under the previous supply agreement.
2024年11月1日,诺瓦瓦克斯医药公司与英国卫生安防-半导体局签署了一份终止与和解协议,有效解决了与2022年7月1日签订的修订后的SARS-COV-2疫苗供应协议有关的争议。协议包括诺瓦瓦克斯承诺向卫生安防-半导体局返还12380万美元,分三年按季度付款,还有加快支付以避免利息的选项。首笔付款将于2024年11月30日到期。该协议解决了双方在之前供应协议下的义务和索赔。
2024年11月1日,诺瓦瓦克斯医药公司与英国卫生安防-半导体局签署了一份终止与和解协议,有效解决了与2022年7月1日签订的修订后的SARS-COV-2疫苗供应协议有关的争议。协议包括诺瓦瓦克斯承诺向卫生安防-半导体局返还12380万美元,分三年按季度付款,还有加快支付以避免利息的选项。首笔付款将于2024年11月30日到期。该协议解决了双方在之前供应协议下的义务和索赔。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息